Earnings calls

SMS Pharma. concall ledger

Every earnings call for SMSPHARMA — management tone, guidance, KPIs and promise tracking, quarter by quarter.

SMSPHARMA · 2 transcripts · Healthcare · latest Q2 FY26

Q2 FY26Published 11 Nov 2025Call held 11 Nov 2025

SMSPHARMA Q2 FY26 Earnings Call Transcript & Analysis

Revenue₹242.4 cr+23% YoYEBITDA₹48.3 cr+54% YoYEBITDA Margin20%PAT₹25.3 cr+80% YoYPAT Margin10%

Revenue (Q2 FY26) ₹242 cr (+23% YoY); EBITDA (Q2 FY26) ₹48 cr (+54% YoY); EBITDA Margin (Q2 FY26) 20.0%. PAT grew 80% YoY to INR25.3 crores, highest ever in a single quarter.

Read full transcript & analysis

Q4 FY25Published 02 Jun 2025Call held 02 Jun 2025

SMSPHARMA Q4 FY25 Earnings Call Transcript & Analysis

Revenue₹248 cr+43% YoYEBITDA₹41 cr+21% YoYEBITDA Margin16%PAT₹20 cr+18% YoYPAT Margin8%

Revenue ₹248 cr (+43% YoY); EBITDA ₹41 cr (+21% YoY); EBITDA Margin 16%. FY25 PAT grew 39% YoY to INR69 crores.

Read full transcript & analysis